Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chloride voltage-gated channel 3 pseudogene 1 (CLCN3P1) is a human genomic locus classified as a pseudogene, meaning it is a non-functional segment of DNA derived from a protein-coding gene (here, CLCN3, a chloride channel)[3][5]. Pseudogenes like CLCN3P1 typically do not encode active proteins or direct drug targets, but may play roles in post-transcriptional regulation by serving as decoys for microRNAs or through other RNA-mediated mechanisms[2][4]. There is no evidence that CLCN3P1 possesses ion channel activity or established roles as a therapeutic target. No approved drugs, biomarkers, or known safety issues are associated with CLCN3P1. Its biological relevance is primarily of interest in the context of genomic regulation and pseudogene biology. Key points: - CLCN3P1 does *not* encode a functional chloride channel protein, nor is it a validated therapeutic target[3][5]. - It is distinct from the functional gene **CLCN3**, which encodes a chloride ion channel involved in cellular electrophysiological processes[1]. - The classification "pseudogene" indicates loss of coding potential, with possible (but unconfirmed) roles in gene regulation via non-coding transcripts, similar to documented pseudogene functions such as PTENP1 and KRAS1P[2][4]. If you are looking for information about a functional chloride channel, refer instead to "chloride voltage-gated channel 3" (CLCN3), not this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride voltage-gated channel 3 pseudogene 1 (CLCN3P1).